Press Releases :: BiomX, Inc. (PHGE)

Nov 09, 2021 8:00am EST

BiomX to Host Third Quarter 2021 Financial Results Conference Call and Webcast on November 15, 2021

Oct 18, 2021 7:00am EDT

BiomX Reports Topline Results of Phase 2 Cosmetic Acne Study

Oct 13, 2021 7:00am EDT

BiomX Announces Agreement with Maruho Co., Ltd. for Atopic Dermatitis Product Candidate BX005

Sep 02, 2021 4:05pm EDT

BiomX to Present at Upcoming September Investor Conferences

Aug 16, 2021 6:30am EDT

BiomX Reports Second Quarter 2021 Financial Results and Provides Business Update

Aug 12, 2021 8:00am EDT

BiomX to Host Second Quarter 2021 Financial Results Conference Call and Webcast on August 16, 2021

Jul 26, 2021 8:13am EDT

BiomX Inc. Announces $15 Million Registered Direct Offering

Jun 14, 2021 6:30am EDT

BiomX Presents Preclinical Results With BX005 for Atopic Dermatitis at the Revolutionizing Atopic Dermatitis 2021 Virtual Conference and the International Conference on Phage Therapy and Bacteriophages

Jun 09, 2021 6:30am EDT

BiomX to Present Preclinical Results with BX004 in Cystic Fibrosis at the 44th European Cystic Fibrosis Conference

May 24, 2021 6:30am EDT

BiomX Reports First Quarter 2021 Financial Results and Provides Business Updates

Previous
1…
5
6
7
8
9
10
11
12
13
14
Next

Investor Contact Information

Company

BiomX, Inc.
708 Quince Orchard Rd
Suite 205
Gaithersburg, MD 20878
USA
info@biomx.com

Investor Relations

Ben Cohen
benc@biomx.com